Clinical Trial: 21304

Trial Status: Open
Disease Type: Solid Tumors All
Trial ID 21304
Sponsor ID Toray Industries

A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.(950P1V02)

Principal Investigator
Christina Brzezniak, DO
5 Locations


Alexandria Office

Arlington Office

Fairfax Office

Gainesville Office

Loudoun Office

Learn More About This Trial
Other Relevant Trials
Trial ID TOS-358-001
Sponsor ID Totus

A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-alpha Inhibitor, TOS-358, in Adult Subjects with Select Solid Tumors

Trial ID NP-G2-044-P2-01
Sponsor ID Novita

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies